Clinical Pharmacology Details


GEMFIBROZIL


View Drug Forms

Indications & Dose:

Adjunct to diet and other appropriate measures in mixed hyperlipidaemia if statin contra-indicated or not tolerated


Adjunct to diet and other appropriate measures in primary hypercholesterolaemia if statin contra-indicated or not tolerated


Adjunct to diet and other appropriate measures in severe hypertriglyceridaemia


Adjunct to diet and other appropriate measures in primary prevention of cardiovascular disease in men with hyperlipidaemias if statin contra-indicated or not tolerated



Adult: 1.2 g daily in 2 divided doses, maintenance 0.9–1.2 g daily


 

Contraindications:

Severe hepatic disease, preexisting gallbladder disease, severe renal disease, primary biliary cirrhosis 

Side Effects:

CNS: Fatigue, headache, hypesthesia, paresthesia, vertigo


CV: Atrial fibrillation


EENT: Blurred vision, cataracts, retinal edema


GI: Abdominal pain, constipation, diarrhea, dyspepsia, nausea, taste perversion, vomiting, cholelithiasis


GU: Impotence


HEME: Anemia, bone marrow hypoplasia, eosinophilia, leukopenia, thrombocytopenia


METAB: Increased blood glucose


MS: Arthralgia, myalgia, myasthenia, myopathy, painful extremities, rhabdomyolysis, synovitis


SKIN: Alopecia, dermatitis, exfoliative dermatitis, pruritus


MISC: Weight loss, carcinogenesis


 

Cautions:

Precautions:

Children, cholelithiasis


Pregnancy; excretion into breast milk unknown; use caution in nursing mothers

Interaction:

Drugs 


Binding resins: Reduced bioBrands Available with Cost of gemfibrozil, separate doses by >2 hr


Glyburide: Increased risk of hypoglycemia


HMG  CoA  reductase  inhibitors  (avastatin,simvastatin, atorvastatin): Increased likelihood of drug induced myopathy


Pravastatin: Increased likelihood of drug induced myopathy


Warfarin: Increased hypoprothrombinemic, response to warfarin


 

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: